• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problems Hemorrhage, Subdural (1894); Seizures (2063)
Event Date 04/27/2015
Event Type  Injury  
Manufacturer Narrative
Unique identifier (udi)#: (b)(4).No product is expected for return since we don't have the customer's contact information.
 
Event Description
The customer's lawyer filed a lawsuit alleging that the coaguchek meter (serial number not provided) produced "false and inaccurate" inr results causing her "irreversible and severe injuries." the lawsuit states that "at all relevant times" the coaguchek meter produced results within the customer's therapeutic range.The customer's therapeutic range was not provided.Specific meter results and actions taken based on the meter were not provided.The only information roche has concerning this incident is from the lawsuit.The customer did not contact roche with this complaint.Roche has no further information related to this incident.The lawsuit states that around (b)(6) 2015 the customer started to have severe headaches.On approximately (b)(6) 2015 the customer suffered "multiple injuries" including a seizure and a subdural hematoma.On (b)(6) 2015 the customer underwent an emergency craniotomy to treat the "life-threatening subdural hematoma." the lawsuit states that the customer has had complications on a daily or persistent basis after the subdural hematoma of "aphasia, facial droop, severe headaches, double vision or blurry vision, gastrointestinal bleeding, uncontrollable shaking, difficulty with motor skills, cognitive dysfunction and undesirable side effects of multiple forms of medications to treat these issues." the customer's lawyer states that since the customer relied on the "false and inaccurate" results from the coaguchek meter, this prevented her from taking necessary actions to control her inr results.The lawsuit states that if the coaguchek meter had "safely and reliably" measured the customer's inr, the customer could have made medication adjustments to prevent the "severe injuries and irreversible harm." the lawsuit states that the customer's doctors "determined that the seizure and subdural hematoma were caused by over-coagulation of her blood." since the customer has not contacted roche directly, and we only have the city and state where she resides, we are not able to request the suspect product for return.No product is expected for return to complete the investigation.
 
Manufacturer Narrative
No information was provided in the complaint that would point to a cause for the alleged results.Since no product was returned, the investigation cannot be completed.
 
Manufacturer Narrative
The customer returned the meter and test strips.The test strips were expired and could not be tested.The coaguchek xs meter serial number was (b)(4).Lot number and expiration date were updated.The returned meter was tested in comparison to a retention meter and master lot strips.Human blood samples from warfarin donors were used.Donor 1 inr: 2.2 inr , donor 2 inr: 3.2 inr.Donor 1 hct: 47% , donor 2 hct: 54%.Donor 1: retention meter with master lot strips: 2.2 inr, customer meter with master lot strips: 2.2 inr.Donor 2: retention meter with master lot strips: 3.1 inr , customer meter with master lot strips: 3.1 inr.All inr values were within the specified maximum difference between measurements.No error messages occurred.The returned material and the retention material meet the specifications.The customer's returned meter was additionally tested with controls: qc 1: 2.6 inr , qc 2: 2.6 inr.The obtained qc values were in the allowed range of the used combination master lot strip lot - qc lot.(2.2 - 3.4 inr).All measurements were obtained without error messages.The investigation was unable to find a definitive root cause for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6067592
MDR Text Key58785042
Report Number1823260-2016-01684
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup,Followup
Report Date 06/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/29/2016
Device Catalogue Number04625374160
Device Lot Number230736
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/18/2016
Initial Date FDA Received10/31/2016
Supplement Dates Manufacturer ReceivedNot provided
10/18/2016
10/18/2016
Supplement Dates FDA Received12/12/2016
09/06/2017
06/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-